BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:chloroprocaine readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of chloroprocaine\, from ClinicalTrials.gov 
 estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07895420-5080@assetmemo.bio
DTSTAMP:20261121T005729Z
DTSTART;VALUE=DATE:20261230
DTEND;VALUE=DATE:20261231
SUMMARY:chloroprocaine: Phase 4 readout est. (NCT07895420)
DESCRIPTION:chloroprocaine\, phase 4.\nStudy: Comparing Intravitreal Inject
 ion Pain Scores Using Iheezo (Chloroprocaine Hcl Ophthalmic Gel 3%) Versus
  Subconjunctival Lidocaine (2%): A Randomized\, Controlled Trial\nEstimate
 d primary completion: 30 December 2026. This is a ClinicalTrials.gov estim
 ate\, not a confirmed readout date\, and it can move.\nDrug page: https://
 assetmemo.bio/drug/chloroprocaine#upcoming-events\nRegistry record: https:
 //clinicaltrials.gov/study/NCT07895420
URL:https://assetmemo.bio/drug/chloroprocaine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07239999-5080@assetmemo.bio
DTSTAMP:20261121T005729Z
DTSTART;VALUE=DATE:20270404
DTEND;VALUE=DATE:20270405
SUMMARY:chloroprocaine: Phase 4 readout est. (NCT07239999)
DESCRIPTION:chloroprocaine\, phase 4.\nStudy: Comparing Spinal Anesthesia W
 ith 1% Chloroprocaine Versus 1% Mepivacaine in Patients Undergoing Outpati
 ent Primary Total Knee Arthroplasty\nEstimated primary completion: 4 April
  2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout dat
 e\, and it can move.\nDrug page: https://assetmemo.bio/drug/chloroprocaine
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT072
 39999
URL:https://assetmemo.bio/drug/chloroprocaine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07348614-5080@assetmemo.bio
DTSTAMP:20261121T005729Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:chloroprocaine: Phase 4 readout est. (NCT07348614)
DESCRIPTION:chloroprocaine\, phase 4.\nStudy: Flex Appeal: Evaluating the E
 fficacy of Anesthetic Techniques for Manipulation of Knees Under Anesthesi
 a\nEstimated primary completion: August 2027. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/chloroprocaine#upcoming-events\nRegistry record: 
 https://clinicaltrials.gov/study/NCT07348614
URL:https://assetmemo.bio/drug/chloroprocaine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07839039-5080@assetmemo.bio
DTSTAMP:20261121T005729Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:chloroprocaine: Phase na readout est. (NCT07839039)
DESCRIPTION:chloroprocaine\, phase na.\nStudy: A Pilot Study Comparison of 
 Programmed Intermittent Bolus Versus Continuous Infusion\nEstimated primar
 y completion: December 2028. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/chloroprocaine#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT07839039
URL:https://assetmemo.bio/drug/chloroprocaine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
